Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The main aim is to investigate the effects of acupuncture on pain intensity and health-related quality of life in women with primary dysmenorrhea.
In this randomized controlled clinical trial, 64 women with primary dysmenorrhea were randomly assigned to an acupuncture group (AG; n = 30) or a control group (CG; n = 34). The AG received manual body acupuncture every other day for three menstrual cycles (five sessions per cycle, total of 15 sessions), starting 3-4 days before menstruation in each cycle. The CG received routine recommendations without additional intervention. Pain intensity, functional and emotional impact, and quality of life were assessed using the Visual Analog Scale (VAS), Functional and Emotional Dysmenorrhea Scale (FEDS), and the Short Form-36 (SF-36). Measurements were performed at baseline and on days 30, 60, and 90.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Acupuncture Group (AG) | Experimental | Patients in the AG received classical body acupuncture. The acupuncture points used were: LI-4, LIV-3, KID-3, SP-6, SP-8, HT-7, LU-9, P-6, BL-57, ST-25,28,29,30,36, GV-20, CV-2,3,4,5,6. |
|
| Control Group (CG) | Active Comparator | The control group received no acupuncture session but continued NSAID therapy (400 mg ibuprofen three times daily during menstruation) and routine follow-up. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| acupuncture | Other | classical body acupuncture with needle without electrical stimulation |
|
| Measure | Description | Time Frame |
|---|---|---|
| Visual Analog Scale (VAS) | VAS measures pain severity | 3 months |
| Measure | Description | Time Frame |
|---|---|---|
| The Functional and Emotional Dysmenorrhea Scale (FEDS) | FEDS evaluates the multidimensional impact of dysmenorrhea on participants' daily functioning and emotional well-being | 3 months |
| Short Form-36 (SF-36) |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Ataturk University Hospital | Erzurum | 25040 | Turkey (Türkiye) |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D010146 | Pain |
| ID | Term |
|---|---|
| D009461 | Neurologic Manifestations |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
Not provided
Not provided
| ID | Term |
|---|---|
| D015670 | Acupuncture Therapy |
| D000894 | Anti-Inflammatory Agents, Non-Steroidal |
| ID | Term |
|---|---|
| D000529 | Complementary Therapies |
| D013812 | Therapeutics |
| D018712 | Analgesics, Non-Narcotic |
| D000700 | Analgesics |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| NSAIDs | Drug | NSAID therapy (400 mg ibuprofen three times daily during menstruation) and routine follow-up |
|
SF-36 measures quality of life.
| 3 months |
| D018689 |
| Sensory System Agents |
| D018373 | Peripheral Nervous System Agents |
| D045505 | Physiological Effects of Drugs |
| D020228 | Pharmacologic Actions |
| D020164 | Chemical Actions and Uses |
| D000893 | Anti-Inflammatory Agents |
| D045506 | Therapeutic Uses |
| D018501 | Antirheumatic Agents |